Cancer R&D meets regulatory uncertainty at ASCO25

Wednesday, June 4, 2025 | 11:00 AM - 1:00 PM ET

ASCO sets the stage for cancer progress every year — but which therapies are the ones to watch? We’re digging into the data readouts and assessing pipeline momentum as we unpack the major oncology R&D headlines out of Chicago.

The Trump FDA has tossed the rulebook, leaving biopharma execs scrambling to understand what this means for their cancer pipelines and commercial roadmaps. This year’s meeting couldn’t come at a more critical time.

Follow our coverage online — then join conversations with key industry leaders as they break down the highlights from the biggest cancer conference of the year. Join us online on Wednesday, June 4th.

SPONSORED BY